Skip to main content
. 2024 Feb 23;20:16. doi: 10.1186/s13223-024-00881-z

Table 3.

Basic characteristics of all subjects in validation cohort

Variables Total (n = 120) Case (n = 69) Control (n = 51) p-value
Age, median (Q1,Q3) 33 (24, 46) 35 (24, 46) 31 (22, 46) 0.294
Sex, n (%) 0.860
 Male 67 (56%) 39 (57%) 28 (55%)
 Female 53 (44%) 30 (43%) 23 (45%)
IgE, median (Q1,Q3) 53 (16, 190) 148 (45, 299) 16 (8, 29)  < 0.001
Family history, n (%)  < 0.001
 No 81 (68%) 30 (43%) 51 (100%)
 Yes 39 (32%) 39 (57%) 0 (0%)
Drug allergy, n (%) 0.003
 No 98 (82%) 51 (74%) 47 (92.16%)
 Yes 21 (18%) 18 (26%) 4 (7.84%)